Michigan has operated a medical cannabis program longer than most states in the country. Voters approved the Michigan Medical Marihuana Act (MMMA) by ballot in November 2008, and the program became effective the following month.

A decade later, in November 2018, voters approved a separate measure legalizing adult-use recreational cannabis. Both programs continue to operate side by side, administered by the state’s Cannabis Regulatory Agency (CRA).

For Michigan residents managing chronic conditions, the question of whether to obtain a medical card has shifted considerably in 2026. A new tax law and the continued expansion of telehealth-based certification have together made the medical program more accessible and more financially meaningful than it has been in years.

How the 2026 Tax Change Affects Medical Patients

On January 1, 2026, Michigan’s new 24% wholesale marijuana tax took effect. The tax was enacted in October 2025 as part of the Comprehensive Road Funding Tax Act (HB 4951), signed by Governor Whitmer on October 7, 2025.

It applies to the first sale or transfer of adult-use cannabis from a licensed marijuana establishment to a retail licensee, layered on top of the existing 10% excise tax and 6% state sales tax. The wholesale tax is paid by cultivators and processors but typically passes through to retail prices for recreational consumers.

Medical patients are exempt from both the 24% wholesale tax and the 10% excise tax. They continue to pay only the 6% state sales tax. The result is a substantially wider price gap between medical and recreational purchases than existed in previous years.

For patients who use cannabis regularly for chronic symptom management, the annual savings can run into the hundreds or low thousands of dollars.

This change has reshaped the basic financial calculation for any Michigan resident considering enrollment in the medical program. The $40 state card fee plus a physician evaluation pays for itself relatively quickly under the new tax structure.

Qualifying Conditions and Who Can Certify

Michigan recognizes a broad list of qualifying debilitating medical conditions under the MMMA. The statute itself lists conditions including cancer, glaucoma, HIV/AIDS, hepatitis C, ALS, Crohn’s disease, agitation of Alzheimer’s disease, and nail patella.

The Cannabis Regulatory Agency has subsequently approved additional conditions including PTSD, autism, OCD, Parkinson’s disease, arthritis, rheumatoid arthritis, spinal cord injury, ulcerative colitis, and Tourette’s syndrome. The law also covers any chronic or debilitating condition or treatment that produces severe and chronic pain, cachexia or wasting syndrome, seizures, severe nausea, or severe and persistent muscle spasms.

Only Michigan-licensed Doctors of Medicine (MD) or Doctors of Osteopathic Medicine (DO) may sign the physician certification form. Nurse practitioners and physician assistants are not authorized to certify patients. Applicants must be Michigan residents and at least 18 years old to apply independently. Minors may qualify with parental consent and certifications from two qualified physicians.

The Telehealth Pathway

Michigan’s Cannabis Regulatory Agency has authorized telehealth evaluations for medical cannabis certification, and the entire process can now be completed online for most patients. A patient schedules a video consultation with a

Michigan-licensed physician, reviews their medical history and current symptoms, and receives a signed physician certification if they qualify. The certification is then submitted through Michigan’s LARA online portal along with the $40 state registration fee.

Obtaining a Michigan medical card by telehealth is particularly useful for patients in rural counties, parents managing busy family schedules, and anyone for whom an in-person clinic visit is impractical. The telehealth consultation itself typically takes 10 to 20 minutes.

Under MCL 333.26426, the CRA has up to 15 business days to approve or deny an application and an additional 5 business days to issue the card, for a total of up to 20 business days from receipt of a complete application. Cards are valid for two years before renewal is required, one of the longest validity periods of any state medical cannabis program.

Additional Patient Benefits

Beyond the 2026 tax savings, Michigan medical patients receive several practical advantages. They may possess up to 2.5 ounces of usable cannabis on their person and up to 10 ounces in their residence, with amounts above 2.5 ounces stored in a locked container.

Under Section 4 of the MMMA, registered patients are also permitted to cultivate up to 12 cannabis plants for personal use in an enclosed, locked area at their residence. Many dispensaries reserve dedicated lanes or priority access for medical cardholders, which can reduce wait times during busy hours.

Patients should treat the certification visit as they would any other clinical appointment. That means reviewing current medications with the certifying physician, since cannabinoids interact with the cytochrome P450 enzyme system and may affect drugs including blood thinners, certain antidepressants, and some seizure medications. Ongoing communication with a primary care provider helps integrate medical cannabis into a patient’s broader care plan.

Michigan’s combination of longstanding program history, broad qualifying condition list, two-year card validity, telehealth-based certification, and now-significant tax savings has positioned the state’s medical program as one of the most accessible in the country. For Michigan residents who use cannabis for ongoing symptom management, the 2026 policy environment makes a strong case for completing the certification process.